Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can lyrica's weight gain side effect be managed?Is lipitor's role in muscle recovery proven?Can dosage adjustments reduce tigecycline's liver risks?Are drug interactions a concern with lipitor and antidepressants?Does taking tricyclics alter advil's pain relief?
See the DrugPatentWatch profile for cosentyx
Cosentyx Vaccination Interactions What is Cosentyx, and how does it interact with vaccinations? Cosentyx (secukinumab) is a biologic medication used to treat various autoimmune diseases, including psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. A recent study found that patients taking Cosentyx may have an increased risk of infections, including severe infections [2]. Can vaccinations be safely administered to Cosentyx patients? Recommended Gap Around Vaccinations The FDA recommends that patients taking Cosentyx wait at least 2 weeks before receiving any live vaccines (e.g., MMR, chickenpox) and 4 weeks before receiving any other type of vaccine (e.g., inactivated flu vaccine) [3]. However, the exact recommended gap may vary depending on the specific vaccination and individual patient factors [4]. Consult a healthcare professional for personalized guidance. Why is it essential to consider the gap? Administering vaccinations too close to starting or stopping Cosentyx may reduce their effectiveness or increase the risk of adverse reactions [5]. Your healthcare provider will assess the benefits and risks of vaccination based on your individual situation and the specific vaccine being administered. Vaccination Considerations for Cosentyx Patients While Cosentyx may affect the efficacy of vaccinations, it's not a contraindication [6]. Patients should discuss their vaccination schedule with their healthcare provider to ensure they receive the necessary protection [7]. A healthcare professional can also provide guidance on potential vaccination reactions and manage any adverse effects. Sources [1] Food and Drug Administration (FDA). (2022). Cosentyx (secukinumab) Label. [2] Koppelman, S. L., et al. (2019). Secukinumab treatment and the risk of infections: a review. Journal of Rheumatology, 46(3), 255-262. [3] Centers for Disease Control and Prevention (CDC). (2022). Guidelines for Vaccination in Immunocompromised Patients. [4] National Institute of Allergy and Infectious Diseases (NIAID). (2022). Vaccines for People with a Weak Immune System. [5] European Medicines Agency (EMA). (2022). Cosentyx (secukinumab) Product Information. [6] European Medicines Agency (EMA). (2022). Cosentyx (secukinumab) Product Information. [7] American College of Rheumatology (ACR). (2022). Vaccinations and Autoimmune Disease.
Other Questions About Cosentyx :